Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
about
Prevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in RwandaAntiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionAntiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionAntiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan AfricaEffectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, prospective cohort studyWhat will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysisDevelopment of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, MozambiqueMaternal health and HIV.High Rates of Exclusive Breastfeeding in Both Arms of a Peer Counseling Study Promoting EBF Among HIV-Infected Kenyan WomenImpact of nevirapine (NVP) plasma concentration on selection of resistant virus in mothers who received single-dose NVP to prevent perinatal human immunodeficiency virus type 1 transmission and persistence of resistant virus in their infected childrSystematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission.The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study.HIV: mother-to-child transmissionHIV prevention is not enough: child survival in the context of prevention of mother to child HIV transmissionPersistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy.Development of topical microbicides to prevent the sexual transmission of HIVReviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand.Protein adducts as prospective biomarkers of nevirapine toxicity.Improving a mother to child HIV transmission programme through health system redesign: quality improvement, protocol adjustment and resource addition.Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure.Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study.Detection of HIV-1 drug resistance in women following administration of a single dose of nevirapine: comparison of plasma RNA to cellular DNA by consensus sequencing and by oligonucleotide ligation assay.Ultrasensitive detection of minor drug-resistant variants for HIV after nevirapine exposure using allele-specific PCR: clinical significance.HIV: prevention of mother-to-child transmission.Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South AfricaAntiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa.A window into a public program for prevention of mother to child transmission of HIV: evidence from a prospective clinical trialMaking it happen: prevention of mother to child transmission of HIV in rural Malawi.Outcome of HIV-exposed uninfected children undergoing surgery.Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART.Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapineUsing HIV transmission networks to investigate community effects in HIV prevention trials.Antiretroviral resistance among HIV type 1-infected women first exposed to antiretrovirals during pregnancy: plasma versus PBMCsFetal allostimulation of maternal cells: a potential mechanism for perinatal HIV transmission following obstetrical hemorrhage.Impact of HIV/Aids on Child Mortality before the Highly Active Antiretroviral Therapy Era: A Study in Pointe-Noire, Republic of Congo.Virtual Elimination of Mother-to-Child Transmission of Human Immunodeficiency Virus in Mothers on Highly Active Antiretroviral Therapy in Enugu, South-Eastern NigeriaReducing mother-to-child transmission of HIV: findings from an early infant diagnosis program in south-south region of Nigeria.
P2860
Q21034187-CD01EBBF-30A0-4820-9A86-FA21C5EEB7A1Q24235500-A6773660-1569-420D-BB6A-C7996A714FB6Q24243146-E51106EB-D917-468E-8BFB-10C8B0D3DF65Q27014960-9C8F989B-536B-4E6E-B71F-8989F6BAFC1DQ28472889-98B0A36C-BEA8-47AE-8705-A03573202247Q28478769-20CBFDA3-1AE7-48C9-83C0-3EF36808D9BCQ28546418-79922B0D-3D61-44A0-A5F7-1BBD6ECA4795Q29395564-761CC07E-FC59-47B3-BC05-34BDD93002E0Q30724659-D5228C25-AFE0-4FFA-8A35-3204EE226781Q33267065-0BFEE3C4-4617-4B60-A2FA-4E9CA43FD86BQ33284135-EB9E8D9C-C5DA-4EA2-952C-C17C72DA73CCQ33294899-028C9730-3B15-441B-A887-6F34AE064261Q33320539-B71DB650-9B66-4FA7-9A51-E9B7E8A9F9EFQ33332191-CE592364-846F-4FC4-A082-61479F8E7E4CQ33446714-5AB666DC-8EFD-4F44-B506-109BEB2AC5B7Q33552646-45089C68-3780-48BC-A311-9751AB43EA9CQ33605273-A1884457-2577-47A4-B6A6-184946BEE0A3Q33625073-398C6A60-7CC3-4E31-8C1A-58621566FEFAQ33626116-304EDAA4-A3B8-420D-B156-E2C596D81E62Q33681307-3749777B-183D-4214-8F43-D4408798C9C7Q33749791-5EE60B16-082C-424C-AA55-5E9F87DF608AQ33798282-BFB9115C-8A9B-478C-9B3E-39A75171A083Q33814942-7031F116-B184-4B8D-BA7A-91DA1F074D63Q33827080-D289D843-6593-4D34-A0A7-24B2E372520FQ33827841-F66D5233-41A8-42B6-99B5-3CEF16727DD3Q33866493-F4D55259-0EDE-444A-8460-2BD821D0FC4FQ33893057-F66472CC-7CEF-4008-8490-137F7CBE4AA1Q33897042-DCA8EC37-F6FF-41F5-AD4A-E20965656C12Q33944686-BFDE6CA3-4DE7-4117-9A69-8A7707870687Q33957973-A33C7CA3-6D88-4D09-BA1B-C8C1B7C81198Q33961098-E210633B-09A3-4F83-B889-5EC74F4AC7A9Q33975478-FB61000A-3497-4340-9C7A-465835C30C42Q34019433-5D99D311-32C1-43D9-8827-A82E2EA45839Q34071112-20F79787-0590-4A3C-9AE8-8EE200CBCE0FQ34082835-803B0FF2-042D-4621-96B1-2BB294869D36Q34085343-E0A606E4-C3FB-4029-9BE8-1F7553F9F83CQ34085345-93A00BD0-4EDB-4752-867A-CC66EC655147Q34106178-C36FBA18-D924-4DA3-A0ED-1DD581FA0B92Q34162417-4D0865DC-9E30-4CF6-802F-6F4C78E82D1AQ34191977-14A2A64F-8A5B-4D12-B911-CBBE5D331753
P2860
Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Single-dose perinatal nevirapi ...... smission of HIV-1 in Thailand.
@en
Single-dose perinatal nevirapi ...... smission of HIV-1 in Thailand.
@nl
type
label
Single-dose perinatal nevirapi ...... smission of HIV-1 in Thailand.
@en
Single-dose perinatal nevirapi ...... smission of HIV-1 in Thailand.
@nl
prefLabel
Single-dose perinatal nevirapi ...... smission of HIV-1 in Thailand.
@en
Single-dose perinatal nevirapi ...... smission of HIV-1 in Thailand.
@nl
P2093
P50
P356
P1476
Single-dose perinatal nevirapi ...... smission of HIV-1 in Thailand.
@en
P2093
Jean Yves Mary
Kenneth McIntosh
Perinatal HIV Prevention Trial (Thailand) Investigators
Siripon Kanshana
Sophie Le Coeur
Suporn Koetsawang
Vallop Thaineua
P304
P356
10.1056/NEJMOA033500
P407
P577
2004-07-09T00:00:00Z